Q-Med (UK) Ltd
6th Floor, 10 Dean Farrar Street, London, United Kingdom, SW1H 0DX
Tel: 020 7976 3290 | Web: http://www.restylane.co.uk | Email: info@q-med.com
For over 10 years, RESTYLANE has provided aesthetic practitioners with the ultimate tool to counter the signs of ageing. Today, RESTYLANE has been used in over 10 million treatments worldwide, delivering long-lasting natural results, proven safety and a level of versatility unsurpassed by any other HA-based instant aesthetic treatment.
Q-Med is a rapidly growing and profitable biotechnology/medical device Group. The majority of the products are based on the company's patented technology, NASHA™ for the production of stabilized non-animal hyaluronic acid. Q-Med has been run in its present form since 1995. The Group today has more than 650 co-workers in 20 countries, with close to 400 at the company's head office and production facility in Uppsala, Sweden.
